Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors by Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin

Get full text

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes by Alex C Spyropoulos, Sharyl Magnuson, Sei Keng Koh

Get full text

The underrecognized prothrombotic vascular disease of COVID‐19 by Kevin P. Cohoon, Guillaume Mahé, Alex C. Spyropoulos

Get full text

Emergence of institutional antithrombotic protocols for coronavirus 2019 by Kevin P. Cohoon, Guillaume Mahé, Alfonso J. Tafur, Alex C. Spyropoulos

Get full text

Venous thromboembolism risk and its assessment in hospitalized patients by Andrew N. Nicolaides, Jawed Fareed, Alex C Spyropoulos, Joe Caprini, Paolo Prandoni

Get full text

Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis by Craig I. Coleman, Gregory Piazza, Veronica Ashton, Thomas J. Bunz, Alex C. Spyropoulos

Get full text

Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Sta... by Jerrold H. Levy, Jean M. Connors, Marie E. Steiner, James Douketis, Alex C. Spyropoulos

Get full text

Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis by Jason J. Wang PhD, Ioannis Koulas MD, MSc, Anne Myrka BS Pharm, MAT, Alex C. Spyropoulos MD

Get full text

A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant by James D. Douketis, Summer Syed, Na Li, Samer Narouze, Mansoor Radwi, Joanne Duncan, Sam Schulman, Alex C. Spyropoulos

Get full text

Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER by Gary E. Raskob, Alex C. Spyropoulos, Theodore E. Spiro, Wentao Lu, Zhong Yuan, Bennett Levitan, Eunyoung Suh, Elliot S. Barnathan

Get full text

Occurrence of Thromboembolic Events and Mortality Among Hospitalized Coronavirus 2019 Patients: Large Observational Cohort Study of Electronic Health Records by Alex C. Spyropoulos, James M. Crawford, Yen-Wen Cindy Chen, Veronica Ashton, Alicia K. Campbell, Dejan Milentijevic, W. Frank Peacock

Get full text

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis by Alex C. Spyropoulos, Concetta Lipardi, Jianfeng Xu, Colleen Peluso, Theodore E. Spiro, Yoriko De Sanctis, Elliot S. Barnathan, Gary E. Raskob

Get full text

Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study by Alex C. Spyropoulos, Gary E. Raskob, Theodore E. Spiro, Wentao Lu, Yoriko De Sanctis, John Albanese, Alexandre Mebazaa, Elliot S. Barnathan

Get full text

Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation Study by Kira MacDougall, James D. Douketis, Na Li, Nathan P. Clark, Alfonso Tafur, Julien D'Astous, Joanne Duncan, Sam Schulman, Alex C. Spyropoulos

Get full text

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study by Alfonso J. Tafur, Nathan P. Clark, Alex C. Spyropoulos, Na Li, Eric Kaplovitch, Kira MacDougall, Sam Schulman, Joseph A. Caprini, James Douketis

Get full text

Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure Hospitalization by Pulkit Chaudhury, Paulino Alvarez, Madonna Michael, Marwan Saad, G. Jay Bishop, Mazen Hanna, Venu Menon, Randall C. Starling, Alex C. Spyropoulos, Milind Desai, Amgad Mentias

Get full text

Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 by Luis H. Paz Rios, Iva Minga, Esther Kwak, Ayman Najib, Ashley Aller, Elizabeth Lees, Victor Macrinici, Kaveh Rezaei Bookani, Amit Pursnani, Joseph Caprini, Alex C. Spyropoulos, Alfonso Tafur

Get full text

The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification by C. Michael Gibson, Alex C. Spyropoulos, Alexander T. Cohen, Russell D. Hull, Samuel Z. Goldhaber, Roger D. Yusen, Adrian F. Hernandez, Serge Korjian, Yazan Daaboul, Alex Gold, Robert A. Harrington, Gerald Chi

Get full text

Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution by Marc Cohen, MD, Alex C. Spyropoulos, MD, Shaun G. Goodman, MD, Sarah A. Spinler, PharmD, Marc P. Bonaca, MD, Theresa M. Redling, DO, Gautam Visveswaran, MD, Sumit Sohal, MD, MS

Get full text

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds by Alex C. Spyropoulos MD, Bríain Ó Hartaigh PhD, Zhun Cao PhD, MA, Harjeet Caberwal PharmD, Craig Lipkin MS, Michaela Petrini PA-C, MHS, Cheng Wang MD, PhD

Get full text